NCT06967922 Impact of Analytic-integrative Cognitive Behavioural Therapy on Acute Insomnia Disorder (Stress)
| NCT ID | NCT06967922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Acute Insomnia Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study, conducted in a population with acute insomnia disorder (stress), was to investigate the efficacy of Analytic-Integrative Cognitive Behavioural Therapy in the treatment of acute insomnia disorder (stress).
Eligibility Criteria
Inclusion Criteria: 1. meeting the DSM-5 diagnostic criteria for insomnia disorder; 2. a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI); 3. age ≥18 years old, with junior high school education or above; 4. voluntarily participating in this study and signing an informed consent form; 5. the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months). Exclusion Criteria: 1. people with comorbid serious physical or severe mental illnesses, suicide risk; 2. clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers; 3. pregnant and breastfeeding women; 4. people who are currently undergoing any psychological treatment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06967922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Insomnia Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06967922 currently recruiting?
Yes, NCT06967922 is actively recruiting participants. Contact the research team at wanghongxing@xwh.ccmu.edu.cn for enrollment information.
Where is the NCT06967922 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06967922 clinical trial?
NCT06967922 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.